These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15360020)

  • 1. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
    Heartin E; Walkinshaw S; Clark RE
    Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy outcome of two patients treated with imatinib.
    Prabhash K; Sastry PS; Biswas G; Bakshi A; Prasad N; Menon H; Parikh PM
    Ann Oncol; 2005 Dec; 16(12):1983-4. PubMed ID: 16100234
    [No Abstract]   [Full Text] [Related]  

  • 3. Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
    Yilmaz M; Demirhan O; Kuçukosmanoglu E; Pehlivan M; Okan V; Balat O; Pehlivan S
    Leuk Lymphoma; 2007 Dec; 48(12):2454-6. PubMed ID: 18067024
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
    Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloid leukemia. Sceptical scientists.
    Druker BJ
    Lancet; 2001 Dec; 358 Suppl():S11. PubMed ID: 11784560
    [No Abstract]   [Full Text] [Related]  

  • 6. Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy.
    Meera V; Jijina F; Shrikande M; Madkaikar M; Ghosh K
    Leuk Res; 2008 Oct; 32(10):1620-2. PubMed ID: 18420270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester.
    Suppiah R; Kalaycio M
    Leuk Lymphoma; 2006 Jun; 47(6):1149-50. PubMed ID: 16840209
    [No Abstract]   [Full Text] [Related]  

  • 8. Imatinib mesylate in the treatment of chronic myeloid leukaemia.
    Druker BJ
    Expert Opin Pharmacother; 2003 Jun; 4(6):963-71. PubMed ID: 12783592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete cytogenetic and molecular response to treatment with imatinib mesylate for philadelphia chromosome positive acute myeloid leukemia with multilineage dysplasia.
    Ueda K; Horiike S; Zen K; Misawa S; Taniwaki M
    Leuk Lymphoma; 2006 Sep; 47(9):1967-9. PubMed ID: 17065015
    [No Abstract]   [Full Text] [Related]  

  • 10. Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response.
    Kuwabara A; Babb A; Ibrahim A; Milojkovic D; Apperley J; Bua M; Reid A; Foroni L; Rezvani K; Goldman J; Marin D
    Blood; 2010 Aug; 116(6):1014-6. PubMed ID: 20705771
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib mesylate.
    Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
    Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
    Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3. Imatinib therapy in chronic myelogenous leukemia.
    Jinnai I
    Intern Med; 2007; 46(2):95-7. PubMed ID: 17220607
    [No Abstract]   [Full Text] [Related]  

  • 14. Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?
    White DL
    Leuk Lymphoma; 2008 Jun; 49(6):1022-3. PubMed ID: 18452091
    [No Abstract]   [Full Text] [Related]  

  • 15. Pregnancy on imatinib: fatal outcome with meningocele.
    Choudhary DR; Mishra P; Kumar R; Mahapatra M; Choudhry VP
    Ann Oncol; 2006 Jan; 17(1):178-9. PubMed ID: 16291579
    [No Abstract]   [Full Text] [Related]  

  • 16. Issues of imatinib and pregnancy outcome.
    Apperley J
    J Natl Compr Canc Netw; 2009 Nov; 7(10):1050-8. PubMed ID: 19930974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment for de novo chronic myeloid leukemia in chronic phase].
    Hirase C; Matsumura I
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():298-303. PubMed ID: 23133971
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of molecular remission throughout pregnancy in CML after imatinib.
    Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
    Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
    [No Abstract]   [Full Text] [Related]  

  • 19. David A. Karnofsky Award lecture. Imatinib as a paradigm of targeted therapies.
    Druker BJ
    J Clin Oncol; 2003 Dec; 21(23 Suppl):239s-245s. PubMed ID: 14645403
    [No Abstract]   [Full Text] [Related]  

  • 20. Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: treatment outcomes with imatinib mesylate.
    Mesa RA; Steensma DP; Hoyer J; Ketterling RP
    Br J Haematol; 2003 Oct; 123(2):366-7. PubMed ID: 14531922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.